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Abstract-D,, a subtype of the dopamine receptors, is widely distributed in the nervous system and has 
been shown to be positively coupled to adenylate cyclase. Using a combination of in vitro receptor 
autoradiographic and in situ hybridization techniques, the present study examines the co-distribution of 
D, receptor binding sites and D, receptor messenger RNA in adjacent rat brain sections. D, receptor 
binding sites were labeled using the selective antagonist [‘H]SCH23390 (4.6 nM) in the presence of 1 pM 
ketanserin, while the D, receptor messenger RNA was visualized with a ‘?I-labeled riboprobe correspond- 
ing to a region between transmembrane domains III and VI of the rat D, receptor (bp 3833843). Analysis 
of serial sections suggested a good agreement between D, receptor binding and messenger RNA in several 
brain regions, including the paleocortex, caudate-putamen, nucleus accumbens, amygdala and suprachi- 
asmatic nucleus. Marked discrepancies between D, receptor binding and messenger RNA were observed 
in other brain regions including the entopeduncular and subthalamic nuclei, substantia nigra (pars 
reticulata), hippocampus and cerebellum. While technical considerations may contribute to these results, 
much of the discordance between the distributions is likely due to the differential localization D, receptor 
messenger RNA in cell bodies and receptor binding sites on fibers and may provide insights into receptor 
synthesis, transport and membrane insertion. In the basal ganglia, for instance, D, receptors are 
synthesized in the striatum and are either transported to efferent projections in areas such as the substantia 
nigra, or remain localized in striatal cells bodies. Ibotenic acid lesions in the striatum are consistent with 
these conclusions and demonstrate a coordinate loss of D, receptor binding and messenger RNA in the 
caudatcputamen that is accompanied by a degeneration of fibers projecting to substantia nigra and a 
loss of D, binding in the pars reticulata. Neurons in the dentate gyrus and in the granular layer of the 
cerebellum, on the other hand, synthesize D, receptors and transport them entirely to either their dendritic 
or axonal fields, respectively, in the molecular layer. 
This analysis provides a better understanding of dopaminergic receptor systems in the CNS and their 
anatomical organization. 
Dopamine receptors in the CNS can be differentiated 
into two subtypes referred to as D1 and Dr. Because 
of their clinical relevance in Parkinson’s disease and 
schizophrenia, a great deal of research has been 
generated to localize these receptor sites in the 
CNS 10.‘*,3g examine their regulation following drug 
treatment and lesions5~‘3*M*31 and study the second 
messenger systems to which they are coupled.36 The 
D, dopamine receptor subtype is widely distributed in 
the CNS,2,4*16 can be upregulated by dopamine recep- 
tor antagonists, such as (R)-( + )-8-chloro-2,3,5- 
tetrahydro-3-methyl-5-phenyl-lH-3-benzazepin-7-ol 
(SCH23390),‘**’ and is positively coupled to adenylate 
cyclase via a G, protein. 6,32 D, receptors, on the other 
hand, are abundant in the basal ganglia and pitu- 
tTo whom correspondence should be addressed. 
Abbreviations: EDTA, ethylenediaminetetra-acetate; S-HT, 
5hydroxytryptamine; SCH23390, (R)-( +)-8-chloro- 
2,3,4,5-tetrahydro-3-methyl-5-phenyl-l~-3-~~ze~in- 
7-01; SCH23982, (SR)18-iddo-2,3,4,5-tetrahydro-3- 
methyl-5-phenyl-lH-3-benzazepin-7-01; SSC, sodium 
chloride-sodium citrate buffer. 
itary,39.12 are upregulated following 6-hydroxydopa- 
mine lesions’3*3’ and chronic haloperidol treatment,25 
and are either uncoupled or negatively coupled to 
adenylate cyclase.29 
The recent cloning of the D, receptor’7~30~37*41 has 
provided a new means of examining issues of receptor 
structure, regulation and function. The D1 receptor is 
a 446-amino acid protein and has a 40-M% amino 
acid identity with other cloned catecholamine recep- 
tors including the D2 receptor. Based on hydropho- 
bicity analysis, the receptor appears to have seven 
transmembrane domains and contains no introns 
within its protein coding region. It differs from the D2 
receptor which contains multiple introns and a long 
third cytosolic loop. I’ Transfection of the D, clone 
into COS cells produced the expression of D,-specific 
binding (PHlSCH23390) and a positive coupling to 
adenylate cyclase. 
The goal of this study is to provide a qualitative 
examination of the D, receptor mRNA and binding 
site distributions in the brain using a combination of 
in situ hybridization and receptor autoradiographic 
359 
360 A. MAIZKXJR PI cd 
techniques. An obvious concern in such an analysis 
is that receptor binding sites and mRNA may be 
localized on different neuronal elements. Receptor 
binding is localized on both cell bodies and fibers, 
while mRNA is thought to be localized primarily in 
cell bodies. Therefore, while regions of concordance 
would be expected since the D, receptor mRNA and 
binding sites are products of the same gene, some 
anatomical discordance would not be surprising due 
to differential localization on neuronal fibers. Such a 
lack of correspondence between receptor binding and 
mRNA, in fact, suggests receptor transport within a 
neuron, something with has previously only been 
effectively demonstrated with lesion studies.‘,38 
Given the complexity of this task, this study fo- 
cuses on regions of the CNS with better known 
circuitry, such as the hippocampus, basal ganglia and 
cerebellum, with a minimal discussion of other re- 
gions of the forebrain and midbrain. To aid in 
determining whether the differences observed in re- 
ceptor mRNA and binding are due to a differential 
localization on neuronal fiber, ibotenic acid lesions 
were performed to selectively destroy cell bodies24 and 
trace their degenerating terminals. 
EXPERIMENTAL PROCEDURES 
Tissue preparation and incubarion medium for receptor 
binding srudies 
Adult male SpragueDawley rats (Charles River, 
200-250 g) were killed by decapitation and their brains were 
quickly removed and frozen in liquid isopentane (- 30°C 
30s). Frozen tissues were sectioned on a Bright cryostat 
(2Opm), thaw-mounted on precleaned and subbed micro- 
scope slides, and stored at -80°C. Immediately prior to 
using the tissue, the slide-mounted sections were gradually 
brought to room temperature and incubated (90 min, 22°C) 
with 20&400~1 of the selective D, antagonist 
[3H]SCH233908~22 (71.3 Ci/mmol) in 50 mM Tris buffer (pH 
7.5 at 25°C) containing 0.1% ascorbic acid, 120 mM NaCl, 
5 mM KC1 and 1 mM MgCl, The labeling concentration of 
[3H]SCH23390 (4.6 nM) was chosen to correspond to three 
times the Kh value of the Jigand*’ and results in a 75% 
receptor occupancy. As SCH23390 has been reported to 
bind serotonergic sites (5-HT,), 1 PM ketanserin, a selective 
5-HT, antagonist, was added to all [‘H]SCH23390 binding 
studies. 
Following a 90-min incubation period,the slides were 
drained, washed in four 4-min consecutive 250m1, 50mM 
Tris (pH 7.6, 4°C) washes containing 0.1% ascorbic acid, 
120 mM NaCl, 5 mM KC1 and 1 mM MgCl, All slides were 
then quickly dipped in 250 ml distilled water (4°C) and dried 
with a portable hair dryer set to “cool”. Nonspecific binding 
was evaluated by treating a parallel set of slides with the 
same concentration of tritiated Jigand with a 1 FM final 
concentration of unlabeled SCH23390. The slides were then 
apposed to tritium-sensitive Hypertilm (Amersham) for four 
weeks. The Hype&m was exposed at room temperature, 
developed in Kodak D-19 (4min, 19”C), agitated in 2% 
acetic acid (30 s), fixed in Kodak Rapidfix (5 min), and 
washed under running water (30min). Anatomical struc- 
tures were determined using Nissl-stained sections in con- 
junction with the atlas of Paxinos and Watson.” 
In situ hybridization 
Slides adjacent to those used for autoradiographic map- 
ping of D, binding sites were directly removed from storage 
at -80°C and placed into 4% formaldehyde for 60 min 
(22°C) prior to being processed for I/I SIIL( :rybrrdtl- 
ation.28,“5.40 Following three 5-min rinses in phosphate- 
buffered saline (pH 7.4), sections were treated with 
proteinase K (1 p-g/ml in 100 mM Tris, pH 8.0. 50mM 
EDTA) for 10 min at 37°C. Slides were then rinsed in water. 
followed by 0.1 M triethanolamine @H 8.0), and treated 
with a mixture of 0. I M triethanolamine (pH 8.0) and acetic 
anhydride (400: 1, vol:vol) with stirring for 10 min. ‘The 
sections were then rinsed in 2 x sodium chloride sodium 
citrate buffer (SSC) (300 mM NaCI, 30 mM sodium citrate. 
pH 7.2) for 5 min, dehydrated through graded alcohols. ;md 
allowed to air dry. 
Brain sections were hybridized with a [?3]UTP-labeled 
480-bp riboprobe generated to the region of the rat 
D, receptor spanning transmembranes III-VI (bp 383 
843). cRNA probes generated with a pGEM transcrip- 
tional vector were diluted in hybridization buffer 
(75% formamide, 10% dextran sulfate, 3 x SSC. SOmM 
Na,PO, (pH 7.4). I x Denhardt’s, 0.1 mg/ml yeast tRNA, 
0.1 mg/ml sonicated, denatured salmon sperm DNA, 
1OmM dithiothrietol) to result in a final concentration of 
2 x 10hd.p.m./30~1. Volumes of 30 and 50~1 of diluted 
probe were applied to coronal and horizontal sections. 
respectively. 
After hybridization (overnight, 55’C) the slides were 
rinsed in 2 x SSC (5 min) and treated with RNase A 
(200 pug/ml in 1OmM Tris, pH 8.0, and 0.5 M NaCl) for 
60min at 37°C. Subsequently, sections were rinsed m 
2 x SSC for 10 min (22°C). I x SSC for 10 min (22 C), 
0.5 x SSC at 55°C for. 60 mm, 0.5 x SSC at room tempera- 
ture for IO min. and finally dehydrated in graded alcohols 
and air dried. Sections were then either exposed to Kodak 
XAR-5 X-ray film for three to 10 days and developed, or 
dipped in Kodak NTB-2 emulsion and stored at 4’C prior 
to development 14 days later. 
Ibotenic acid lesions 
Ten male Sprague-Dawley rats (200-25Og) were anes- 
thetized and placed in a Kopf stereotaxic apparatus. To 
ensure that the right rostra1 caudate-putamen was com- 
pletely ablated, ibotenic acid (2.0 pg/pl) dissolved in phos- 
phate-buffered saline was infused at three different 
coordinates in the caudateputamen using a 30-gauge can- 
nula. With skull flat, the coordinates were B + 2.0/2.5/5.5, 
B + 1.0/3.0/5.5 and B- 0.4/4.0/5.5 corresponding in mil- 
limeters to the anterior-posterior/lateral/and ventral planes 
as illustrated in the atlas of Paxinos and Watson.33 An 
infusion of 1 pl was given over a time interval of 2 min at 
each site and the cannula was allowed to remain in place for 
5 min prior to removal. Fourteen days following the lesion, 
animals were killed by decapitation and their brains were 
frozen as described above. Brains were sectioned and pro- 
cessed for in situ hybridization and receptor autoradiog- 
raphy as described above. The extent of neuronal cell loss 
was evaluated with Nissl-stained sections and reference to 
the atlas of Paxinos and Watson.?’ 
“Sense”-strand control 
To assess whether the in situ signal reflected specitic 
hybridization to the D, receptor mRNA, a “sense’‘-strand 
control study was performed whereby a series of paired, 
adjacent sections was divided into two sets. One set of slides 
was treated according to the in situ protocol described 
above, while the second set was treated identically, except 
that the cRNA probe used in the hybridization mixture was 
[“S]UTP labeled sense-strand RNA. 
Materials 
[3H]SCH23390 was purchased from New England Nu- 
clear and the unlabeled SCH23390 was a kind gift from Dr 
James Woods, University of Michigan, Ann Arbor, U.S.A. 
Ibotenic acid was purchased from Vachon Natural Prod- 
ucts. Washington. 
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RESULTS relative to the binding or mRNA levels within this 
D, receptor binding sites were widely distributed in 
anatomical region. 
the CNS with higb levels observed in the basal Te~enCe~~~o~ 
ganglia and amygdaloid nuclei. By comparison, few D, receptor binding sites are seen in all the cortkal 
other regions demonstrate the same high levels of D, divisions and are particularly prominent in the piri- 
receptor binding, but moderate amounts of receptor form and entorhinal cortex. Within the neocortex, 
binding are seen in the septum, superior colliculus superIicia1 layers (I-IV) of the frontal, parietal, tem- 
and the deep layers of cortex. D, receptor mRNA is poral and occipital cortex have low levels of Di 
also widely ~st~but~ in the CNS and generally bin~ng, with deep layers (V and VI) ~rnons~ti~ 
shows a good agreement with the ~s~bution of the moderate amounts. P~~o~cal mgions, such as the 
D, binding sites. Given that the caudate-putamen piriform and entorhinal cortex, demonstrate moder- 
contains high levels of both 0, receptor mRNA and ate to dense binding in layers I, II, V and VI and low 
binding, descriptions of other brain areas are made levels in layers III and IV. Anterior cingulate cortex 
Fig. I. Dark-field autoradiograms comparing D, receptor binding (A, D) and D, receptor mRNA (B, E) 
in the caudat*putamen (CPU), nucleus aaxmbens (ACB) and olfactory tubercle (OTU). Note the high 
levels of D, receptor binding and mRNA in the striatum and olfactory tubercie. Nissl-stained sections 
(C, F) are provided for anatomical referewe. ac, anterior eommissure. 
appears more similar to the neocortical regions, with entorhinal cortex, with moderate levels m lay c’rs f i, L 
moderate levels of D, binding in layers V and VI and and VI and no detectable mRNA in layer 1. Only tow 
low levels in the superficial layers. D, receptor levels of D, receptor mRNA are observed in the deep 
mRNA is also ~redomi~antIy in the piriform and layers (VI) of frontal, parietal, temporal. occipitat 
Fig. 2. Dark-field autoradiograms of D, receptor binding (A, C) and D, receptor mRNA (8, Df in serial 
sections. A good correspondence between D, receptor binding and mRNA is found in the cau- 
date-putamen (CPU), amygdala (AMC) and suprachiasmatic nucleus (SCN), while a discordance is seen 
in the globus paflidus (GP). hippoca~pus (HPC) and thalamus (THE.1 
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and cingulate cortex, and none can be detected in the 
more superficial layers (I-V). Deep layers of the 
medial, lateral and ventral orbital cortex show mod- 
erate D, binding and low levels of mRNA. 
Within the telencephalon, the highest levels of D1 
receptor binding and mRNA are observed in the 
basal ganglia. In the caudate-putamen (Fig. lA,D) 
D, receptor binding is densest in the head of the 
caudate-putamen with a rostral-to-caudal gradient 
observed. In addition, there are medial-lateral differ- 
ences, with the densest binding found in the dorso- 
medial and ventrolateral portions of this nucleus. D1 
receptor mRNA (Fig. lB,E) appears more uniform in 
the caudateputamen, with somewhat higher levels 
observed ventrolaterally. Ventrally in the nucleus 
accumbens, dense levels of DI receptor binding and 
mRNA are observed particularly in the shell and 
extend into the core (Fig. lD,E). Both D, receptor 
binding and mRNA show a rostra1 to caudal gradient 
in the nucleus accumbens, with the highest level of D, 
receptors observed rostrally. The olfactory tubercle 
similarly demonstrates high levels of D, receptors, 
with the D, receptor mRNA levels (Fig. lB,C) ex- 
ceeding those observed in the caudate-putamen and 
nucleus accumbens. 
A region of discordance between D1 receptor 
mRNA and D, receptor binding is the globus and 
ventral pallidum (Fig. 2A,B). In the globus pallidus, 
a region with major projections from the striatum, 
there are low levels of D, receptor binding with 
moderate levels observed in the ventral pallidurn. In 
contrast, only a few cells of either the globus or 
ventral pallidum show D, receptor mRNA. Similarly 
in the septum, moderate levels of D, receptor binding 
are observed in the lateral nucleus with dense binding 
along its outer boundary, yet little D, receptor 
mRNA can be detected. The medial nucleus of the 
septum also shows a low level of D, receptor binding 
and no D, receptor mRNA, suggesting an absence of 
receptor synthesis in this region. 
Within the hippocampal formation and dentate 
gyrus, D, receptor binding is moderate to low, with 
binding observed in the molecular layer of the dentate 
gyrus and in the stratum moleculare of the hippocam- 
pal formation (Fig. 2C). Interestingly, D1 receptor 
mRNA is localized in the granular cell layer of the 
dentate gyrus and no D, receptor mRNA could be 
detected in the hippocampal formation (Fig. 2D). 
This suggests both a transport of D, receptors within 
dentate gyrus and an extra-hippocampal projection 
to the stratum moleculare of the hippocampus. 
The amygdaloid complex, a region with varying 
densities of D, receptor binding, shows a good corre- 
spondence between D, receptor binding and D, re- 
ceptor mRNA (Fig. 3A,B). The basolateral, lateral 
and central nuclei show low levels D, receptor 
mRNA and a moderate amount of D, binding (Fig. 
3). Similarly, moderate to dense levels of D, binding 
and mRNA appear co-localized in the cortical and 
basomedial amygdaloid nuclei (Fig. 3A,B). 
Diencephalon 
The vast majority of the nuclei of the diencephalon 
show only low levels of D, receptor binding. Within 
the hypothalamus, low levels of D, binding are 
observed in most nuclei (Fig. 2C) with somewhat 
higher levels in the arcuate nucleus. Only the 
suprachiasmatic nucleus of the hypothalamus shows 
moderate to dense D, binding (Fig. 2A). Similarly, D, 
receptor mRNA is undetectable in most of the hypo- 
thalamic nuclei with low to moderate levels observed 
only in the suprachiasmatic nucleus (Fig. 2B). More 
dorsally, the thalamus shows only low levels of D, 
receptor binding in most nuclei with the habenula 
demonstrating moderate levels. Di receptor mRNA is 
undetectable in most of the thalamus. 
The entopenduncular nucleus, a region receiving 
projections from the striatum, shows dense levels of 
D, receptor binding and no D, receptor mRNA (Fig. 
4A,B). Such a marked discordance between D, recep- 
tor binding and mRNA suggests that the dopamin- 
ergic binding observed in this nucleus is localized on 
striatal projections. There is dense D, receptor label- 
ing in the caudate-putamen that extends to the 
entopeduncular nucleus and substantia nigra, as can 
be Seen from Fig. 4A. In fact, the D, containing fibers 
appear to course through the internal capsule and 
terminate in the substantia nigra. By comparison, D, 
receptor mRNA (Fig. 4B) is observed only in the 
caudate-putamen which likely contains the cells of 
origin, 
Similarly, the subthalamic nucleus, a region receiv- 
ing projections from the globus pallidus, also demon- 
strates dense D, receptor binding and no D, mRNA 
suggesting that the binding sites are localized on 
fibers. 
Mesencephalon 
In the midbrain, low levels of D, receptor binding 
are observed in the interpeduncular nucleus, peri- 
aqueductal gray, raphe nuclei, inferior colliculus and 
medial geniculate, with the superior colliculus 
demonstrating a moderate density of receptor bind- 
ing (Fig. 5A). Within the dopaminergic cell groups, 
low levels of D, receptor binding can be observed in 
the ventral tegmental area and the pars compacta of 
the substantia nigra, while dense D, binding is found 
in the pars reticulata of the substantia nigra (Figs 4A, 
5A). Despite the presence of D, receptor binding, no 
D, receptor mRNA could be detected in the substan- 
tia nigra, ventral tegmental area, superior and in- 
ferior colliculi, periaqueductal gray, raphe or medial 
geniculate nucleus (Figs 4B, 5B). 
Cerebellum 
Because of its precise lamination, the cerebellum, 
like the hippocampus, is an excellent tissue for exam- 
ining receptor localization. D, receptor binding is 
predominantly in the molecular layer of the cerebel- 
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observed. This layer of the cerebellum receives intrin- 
sic projections from the granular cell layer where low 
to moderate Ievels of D, receptor mRNA can be 
localized (Fig. 5D). 
“&We”-strand controls 
No specific hybridization was observed with sea 
tions labeled with the sense-strand probe, while the 
antisense riboprobe showed specific hybridization 
(data not shown). 
Ibotenic acid lesions 
The ibotenic acid lesions were restricted to the 
caudateputamen and primarily damaged the head 
and the rostra1 portion of the body of the cau- 
~t~u~rnen. Areas of cellular death, as sterns 
by Nissl staining, corresponded precisely to regions of 
D, receptor binding and mRNA loss (Fig. 6A,B). The 
coordinate and nearly complete loss of both D, 
binding and mRNA suggests that the majority of 
D, receptors are localized in cell bodies in the 
Fig. 4. Horizontal rat brain sections mmparing D, receptor bidning (A) and mRNA (It). Dark-field images 
show a good correspondence between D, receptor binding and mRNA iu the caudateputamen (CPU) 
and cortex (CTX). High levels of D, receptor binding but no D, receptor mRNA arc observed in the 
entopeduncular (EP) and substantia nigra (SN). In addition, D, receptors present in fibers of the internal 
capsule (ic) arc probably transported from the striatum to the substantia nigra, pars ret&data. ac, anterior 
commissurc. 
366 A. MANSOUR CI d 
Fig. 5. Dark-field autoradiograms comparing D, receptor binding (A, C) and mRNA (B, D) in coronal 
sections of midbrain and cerebellum. High levets of D, binding are observed in the substantia nigra. pars 
reticulata (SN), while moderate and low levels are seen in the superior colliculus (SC) and periacqueductal 
gray (PAG), respectively. No D, receptor mRNA can be detected in these brain regions. In the cerebellum. 
D, receptor mRNA is localized to the cells of the granular layer (CL), while D, receptor binding is 
predominantly in the molecular layer (ML), suggesting the synthesis and transport of receptors to their 
terminal fields. 
Anatomical comparison of D, 
caudate-putamen. Striatal lesions also produced a 
significant loss of D, receptor binding in the medial 
and central pars reticulata of the substantia nigra 
receptor binding and mRNA 367 
(Fig. 6C) suggesting that the D, receptors found in 





. 6. Dark-field autoradiograms comparing D, receptor mRNA (A) and receptor binding (B, 
owi ng unilateral striatal ibotenic acid lesions. Note the nearly complete loss of D, binding 
.NP L (A) in the lesioned (right) caudate-putamen (CPU) and tire ipsilateral loss of D, receptor 
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DISCUSSION 
A good correspondence between D, receptor bind- 
ing and mRNA was found in areas such as the 
paleocortex, caudate-putamen, nucleus accumbens, 
olfactory tubercle, endopiriform nucleus, suprachias- 
matic nucleus and amygdala. In addition, there ap- 
pears to be a correlation in the relative abundance of 
both D, receptor binding and mRNA, such that 
regions of high receptor binding generally demon- 
strate high levels of D, receptor mRNA, while areas 
of low receptor binding demonstrate little or no 
detectable D, receptor mRNA. The amygdaloid com- 
plex is a particularly good example of such a corre- 
spondence, with specific nuclei displaying varying 
levels of D, receptor binding which correlated pre- 
cisely to the relative amounts of D, receptor mRNA 
found in these areas. 
Similarly, within the dopaminergic terminal fields 
of the basal ganglia, high levels of both D, receptor 
mRNA and binding are observed. In the nucleus 
accumbens, dense levels of D, receptor binding are 
seen in the shell and extend to form islands of very 
dense binding in the core of the nucleus. A gradient 
of D, binding is also seen with binding levels higher 
in the more rostra1 extent of the nucleus accumbens. 
D1 receptor mRNA is similarly localized in the 
accumbens with higher levels observed in the rostra1 
extent, and patches of very dense receptor mRNA are 
observed. In the caudate-putamen, no obvious ros- 
tral to caudal gradient in mRNA levels could be 
detected, while a rostra1 to caudal gradient in recep- 
tor binding was seen in this and in other studies.3Jo,23 
The D, receptor mRNA distribution within the 
caudate-putamen is not homogeneous, however, 
with higher levels observed in the dorsomedial and 
ventrolateral portions of the nucleus-regions that 
correspondingly have higher amounts of D, receptor 
binding. The olfactory tubercle, a third major dopa- 
minergic terminal field, has both high levels of D, 
binding and mRNA. 
Despite an overall good correspondence in D, 
receptor binding and mRNA in the rostra1 forebrain, 
several regions in the CNS fail to show such a 
relationship. A lack of correspondence can be mani- 
fest in one of two ways: either the localization of D1 
receptor binding sites but no D, receptor mRNA, or 
the inverse, a visualization of D, receptor mRNA but 
no D, receptor binding. Examples of each type of 
discordance are observed and may be the result 
of several factors depending on the brain region 
involved. 
Among the technical considerations that may con- 
tribute to this discrepancy in receptor binding and 
mRNA is ligand and probe selectivity. More specifi- 
cally, the ligand or riboprobes chosen may label 
receptors other than D, thereby contributing to a lack 
of correspondence. While a consideration, it is an 
unlikely factor, as [3H]SCH23390 has been reported 
to be a highly selective D, antagonisP* and any 
5-HTz receptor effects it may have should hale been 
blocked with the addition of 1 PM ketanserin used in 
the present study. With regard to the selectivity of the 
riboprobe, the D, receptor is approximately 40% 
homologous to the D2 receptor and the other care- 
cholamine receptors that have been cloned. Given 
such a homology, the conditions used here should 
produce a selective hybridization to the D, receptor 
and studies from our laboratory have, in fact, demon- 
strated that the D, and DZ receptor mRNA distri- 
butions can be easily differentiated in the CNS using 
this riboprobe and these hybridization conditions 
(unpublished observations). However, we cannot rule 
out the possibility that this riboprobe may hybridize 
to a yet uncloned receptor or a variant of the D. 
receptor. 
A second factor that may contribute to a lack of 
correspondence is that of sensitivity. This may be an 
issue in areas with a low density of D, receptors, such 
as most of the nuclei of the hypothalamus and 
thalamus, inferior colliculus, medial septum, interpe- 
duncular nucleus, periaqueductal gray, raphe and 
ventral tegmental area. These regions contain low 
levels of D, receptor binding and no detectable 
mRNA, suggesting a possible lack of sensitivity with 
present in situ hybridization techniques. 
A third technical factor that may influence these 
results is that of differential quenching of the 
isotopes used to label the binding sites and mRNA. 
Clearly, [‘H]SCH23390 is differentially quenched in 
the brain, influencing the grain densities observed in 
various regions. As 35S-labeled riboprobes are 
stronger beta emitters, differential quenching is less of 
a problem, but can still contribute to the results. 
An iodinated ligand could have been used to label 
the D, binding sites; however, differential quenching 
between 35S and “‘1 would still need to be considered. 
Furthermore, no significant anatomical differences 
have been observed between D, binding sites labeled 
with [‘251](5R)-8-iodo-2,3,4,5-tetrahydro-3-methyl-5- 
phenyl-IH-3-benzazepin-7-01 ([‘*‘I]SCH23982) and 
[3H]SCH23390.‘5.26 
While such technical considerations can contribute 
to the results, there are regions in the brain where D, 
receptor mRNA and D, receptor binding can be 
clearly dissociated. Moderate to high densities of D, 
receptor binding are found in the superior colliculus, 
septum, ventral pallidum, entopeduncular nucleus, 
subthalamic nucleus, substantia nigra (pars reticu- 
lata) and the molecular layers of the denate gyrus. 
hippocampus and cerebellum, yet no D, receptor 
mRNA can be detected. Such regions of marked 
discrepancy between D, receptor binding and mRNA 
are likely to be due to a differential localization of 
mRNA in cell bodies, and binding sites on fibers and 
strongly suggest the presence of a specific transport 
of dopaminergic receptors not entirely appreciated 
using receptor autoradiographic techniques alone. 
Based on lesion studies of the nigrostriatal system 
and receptor autoradiographic results.‘,4~‘4.‘9,34.3X sev- 
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era1 investigators have suggested that D, receptor- mRNA can be observed with little or no D, binding, 
containing cells are localized predominantly in the suggesting that the D, receptor is translated and 
striatum and project caudally via the internal capsule transported to sites distant from the point of tran- 
and terminate in the globus pallidus, entopeduncular scription, such as the lateral system or hypothalamus 
nucleus and the pars reticulata of the substantia where Dz binding can be measured. D,-containing 
nigra. Our in situ results are consistent with such a neurons of the substantia nigra, pars compacta, 
scheme and demonstrate D, receptor mRNA only in demonstrate yet another example, with the synthesis 
the striatum and not in any of these projection and transport of the D, receptor to both their soma in 
targets. Our ibotenic acid lesion results are also the substantia nigra and their fibers in the forebrain. 
consistent with previous reports2*4 and demonstrate a It is evident from both the D, and D, receptor results 
coordinate loss of D, receptor mRNA and binding in that different populations of neurons are capable of 
the cells of the striatum and a degeneration of fibers directing the transport and ultimate insertion of 
and loss of D, receptor binding in the substantia receptors to specific regions of their neuronal mem- 
nigra. branes affecting neuronal excitability and specificity. 
Comparison of D, receptor binding and mRNA in 
the nigrostriatal system suggests that striatal neurons 
can synthesize D, receptors which are either trans- 
ported along their fiber projections, or remain local- 
ized within the cell soma itself. This is probably not 
the case in other brain regions, such as the dentate 
gyrus and cerebellum. Neurons in these brain areas 
likely synthesize the D, receptor in their cell bodies 
and transport them mainly to either their dendritic 
(dentate gyrus) or axonal (cerebellum) fields as evi- 
denced by the differential localization of D, receptor 
mRNA in the granular cell layers and D, binding in 
the molecular layers of both the dentate gyrus and 
cerebellum. 
Within the hippocampal formation, D, receptor 
binding is found predominantly in the molecular 
layer, but no D1 mRNA is detected in the pyramidal 
cell layer, suggesting an extra-hippocampal source, 
such as cells in the entorhinal cortex that are known 
to terminate in the molecular layer of the hippo- 
campus. 
Though by no means complete, this analysis pro- 
vides a better understanding of the dopamine recep- 
tor anatomy in terms of both its circuitry and cellular 
elements. While the use of receptor autoradiography 
has been invaluable in understanding the distribution 
of receptor binding sites, it cannot easily dissociate 
which binding sites are localized on cell bodies or 
fibers. Its combination with in situ hybridization 
techniques provides a new means of visualizing po- 
tential circuits and the differential cellular transport 
of receptors. The sensitivity of such an analysis 
largely depends on the anatomical substrate involved, 
with regions of discrete receptor binding, such as the 
suprachiasmatic nucleus, or laminated brain areas, 
such as the cerebellum, hippocampus and olfactory 
bulb being more amenable for this analysis. Similarly, 
well-defined circuits, such as the nigrostriatal system 
are far easier to examine relative to other brain areas. 
In addition to long striatonigral projections, D, 
receptors are apparently localized within local cir- 
cuits. The co-localization of D, receptor mRNA and 
binding in discrete nuclei of the amygdala and the 
suprachiasmatic nucleus, for example, suggest that 
the D, binding sites in these areas are either found on 
cell bodies or are on short or intrinsic projections. 
It is conceivable, however, that despite such a co- 
distribution, the D, receptor mRNA and binding may 
not be localized in the same cells with, for example, 
the D, binding on terminals of one population of cells 
and the mRNA on another within the same nuclei. 
While it is difficult at present to determine the exact 
nature for such a co-localization, the use of electron 
microscopy and immunohistochemistry should be 
able to differentiate these possibilities. 
What remains unclear, however, is which sites are 
functional. Receptor sites in long axonal projections 
may not be coupled to second messenger systems and 
unable to mediate physiological responses. While 
nascent receptors may be able to bind a ligand, they 
may not be functional until they have been inserted 
into terminals or dendritic membranes. Clearly, the 
present results need to be combined with microinjec- 
tion studies to gain a better understanding of the 
anatomical circuitry and physiology. Future studies 
combining these techniques with other anatomical 
methods of visualizing second messengers or phos- 
phinositide tumove? will also be important in re- 
solving these biological issues. 
Comparison of D, receptor mRNA and binding 
similarly suggests that the D, receptor is also differen- 
tially transported within neurons of the CNS.*’ In the 
zona incerta, for example, high levels of D, receptor 
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